Senicapoc

N/A

Report date: 2026/05/08 20:02:52
NME

Base Information

Drug NameSenicapoc
Drug Alias NameICA-17043TRAM-34
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionIntermediate conductance calcium-activated potassium channel protein 4 blockers
TargetsIntermediate conductance calcium-activated potassium channel protein 4
Therapy Area/IndicationsAllergic asthmaCognitive DysfunctionAnemia, Sickle Cell +[10] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesTrinidad and TobagoDenmark +[8] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesIcagen Inc
China Registration ClassN/A

Develop Information

Active CompaniesBiossil IncThe University Of California DavisUniversity Of Copenhagen +[5] 
Inactive CompaniesIcagen Inc
Active IndicationsCognitive DysfunctionAnemia, Sickle CellAlzheimer Disease +[6] 
Inactive IndicationsAllergic asthmaRespiratory Distress Syndrome, AdultAsthma, Exercise-Induced +[4] 

Other Information

ATC CodeN/A
Related LinksWikipediaKEGG